Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 771

1.

Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer.

Zorn KK, Bonome T, Gangi L, Chandramouli GV, Awtrey CS, Gardner GJ, Barrett JC, Boyd J, Birrer MJ.

Clin Cancer Res. 2005 Sep 15;11(18):6422-30.

2.

Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.

Marquez RT, Baggerly KA, Patterson AP, Liu J, Broaddus R, Frumovitz M, Atkinson EN, Smith DI, Hartmann L, Fishman D, Berchuck A, Whitaker R, Gershenson DM, Mills GB, Bast RC Jr, Lu KH.

Clin Cancer Res. 2005 Sep 1;11(17):6116-26.

3.

Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers.

Jazaeri AA, Yee CJ, Sotiriou C, Brantley KR, Boyd J, Liu ET.

J Natl Cancer Inst. 2002 Jul 3;94(13):990-1000.

PMID:
12096084
4.

Use of gene expression profiles to stage concurrent endometrioid tumors of the endometrium and ovary.

Guirguis A, Elishaev E, Oh SH, Tseng GC, Zorn K, DeLoia JA.

Gynecol Oncol. 2008 Feb;108(2):370-6.

PMID:
18083218
5.

Histologic type, organ of origin, and Wnt pathway status: effect on gene expression in ovarian and uterine carcinomas.

Shedden KA, Kshirsagar MP, Schwartz DR, Wu R, Yu H, Misek DE, Hanash S, Katabuchi H, Ellenson LH, Fearon ER, Cho KR.

Clin Cancer Res. 2005 Mar 15;11(6):2123-31.

6.

Opposite alterations of DNA methyltransferase gene expression in endometrioid and serous endometrial cancers.

Xiong Y, Dowdy SC, Xue A, Shujuan J, Eberhardt NL, Podratz KC, Jiang SW.

Gynecol Oncol. 2005 Mar;96(3):601-9.

PMID:
15721400
7.

Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancer.

Maxwell GL, Chandramouli GV, Dainty L, Litzi TJ, Berchuck A, Barrett JC, Risinger JI.

Clin Cancer Res. 2005 Jun 1;11(11):4056-66.

8.

Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt/beta-catenin and PI3K/Pten signaling pathways.

Wu R, Hendrix-Lucas N, Kuick R, Zhai Y, Schwartz DR, Akyol A, Hanash S, Misek DE, Katabuchi H, Williams BO, Fearon ER, Cho KR.

Cancer Cell. 2007 Apr;11(4):321-33.

9.
10.

The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.

Zheng W, Yi X, Fadare O, Liang SX, Martel M, Schwartz PE, Jiang Z.

Am J Surg Pathol. 2008 Feb;32(2):304-15. doi: 10.1097/PAS.0b013e3181483ff8.

PMID:
18223334
11.

beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas.

Moreno-Bueno G, Gamallo C, Pérez-Gallego L, de Mora JC, Suárez A, Palacios J.

Diagn Mol Pathol. 2001 Jun;10(2):116-22.

PMID:
11385321
12.

Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.

Feng W, Marquez RT, Lu Z, Liu J, Lu KH, Issa JP, Fishman DM, Yu Y, Bast RC Jr.

Cancer. 2008 Apr 1;112(7):1489-502. doi: 10.1002/cncr.23323.

13.

Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancer.

Kikuchi R, Tsuda H, Kanai Y, Kasamatsu T, Sengoku K, Hirohashi S, Inazawa J, Imoto I.

Cancer Res. 2007 Aug 1;67(15):7095-105.

14.

Immunophenotypic diversity of endometrial adenocarcinomas: implications for differential diagnosis.

Reid-Nicholson M, Iyengar P, Hummer AJ, Linkov I, Asher M, Soslow RA.

Mod Pathol. 2006 Aug;19(8):1091-100. Epub 2006 Apr 28.

15.

Gene expression profiles in three histologic types, clear-cell, endometrioid and serous ovarian carcinomas.

Pamuła-Piłat J, Rubel T, Rzepecka IK, Olbryt M, Herok R, Dansonka-Mieszkowska A, Grzybowska E, Kupryjańczyk J.

J Biol Regul Homeost Agents. 2014 Oct-Dec;28(4):659-74.

PMID:
25620176
16.

Differential splicing of KLK5 and KLK7 in epithelial ovarian cancer produces novel variants with potential as cancer biomarkers.

Dong Y, Kaushal A, Brattsand M, Nicklin J, Clements JA.

Clin Cancer Res. 2003 May;9(5):1710-20.

17.

High-resolution gene copy number and expression profiling of human chromosome 22 in ovarian carcinomas.

Benetkiewicz M, Wang Y, Schaner M, Wang P, Mantripragada KK, Buckley PG, Kristensen G, Børresen-Dale AL, Dumanski JP.

Genes Chromosomes Cancer. 2005 Mar;42(3):228-37.

PMID:
15578687
18.

Distinctive gene expression profiles by cDNA microarrays in endometrioid and serous carcinomas of the endometrium.

Cao QJ, Belbin T, Socci N, Balan R, Prystowsky MB, Childs G, Jones JG.

Int J Gynecol Pathol. 2004 Oct;23(4):321-9.

PMID:
15381901
19.

Wilms' tumor gene 1 (WT1) in endometrial carcinoma.

Coosemans A, Moerman P, Verbist G, Maes W, Neven P, Vergote I, Van Gool SW, Amant F.

Gynecol Oncol. 2008 Dec;111(3):502-8. doi: 10.1016/j.ygyno.2008.08.032. Epub 2008 Oct 16.

PMID:
18929401
20.

HOXA7 in epithelial ovarian cancer: interrelationships between differentiation and clinical features.

Ota T, Gilks CB, Longacre T, Leung PC, Auersperg N.

Reprod Sci. 2007 Sep;14(6):605-14.

PMID:
17959889

Supplemental Content

Support Center